Sartorius Stedim Japan K.K. Official site

LipidBrick Cell Ready

Lipid-based delivery solutions for ex vivo gene-edited cell therapy.

LipidBrick Cell Ready is an advanced non-viral delivery system using pre-prepared lipid-based nanoparticles. This system is optimized for efficient nucleic acid delivery to various human primary cells, including T cells, NK cells, dendritic cells, and CD34+ hematopoietic stem cells. *For more details, please click on "Download PDF" below. *If you would like a sample, please contact us through "Inquire About Product" below.

Related Link - https://www.sartorius.com/en/products/nucleic-acid…

basic information

Features and Benefits • Cost Efficiency: Ready-to-use reagents that do not require special equipment or consumables • High Performance: Excellent in stable modifications using transient expression and gene editing tools • High Cell Viability: Maintains cell survival, proliferation, and function • Scalability: Optimized from well plate screening to production in bioreactors • Flexibility: Usable for extensive nucleic acid delivery in various immune cells and stem cells

Price range

Delivery Time

Applications/Examples of results

For more details, please refer to the PDF document or feel free to contact us.

LipidBrick Cell Ready: A lipid-based delivery solution for ex vivo gene-edited cell therapy.

PRODUCT

LipidBrick cationic lipid for LNP formulation

PRODUCT

Recommended products

Distributors

Sartorius Stedim, established in 2007 through the merger of the German company Sartorius, founded in 1870, and the French company Stedim, is a pioneer in "Single-Use Technology (SUT)." As a company capable of providing comprehensive technical support to the pharmaceutical and biotechnology industries, its cutting-edge technology is highly regarded worldwide in the fields of scientific instruments and biotechnology.